295 related articles for article (PubMed ID: 29642288)
1. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
[TBL] [Abstract][Full Text] [Related]
2. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
[TBL] [Abstract][Full Text] [Related]
3. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
[TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
Nakamura K; Harada Y; Takahashi H; Trusheim H; Bernhard R; Hamamoto I; Hirata-Saito A; Ogane T; Mizuta K; Konomi N; Konomi Y; Asanuma H; Odagiri T; Tashiro M; Yamamoto N
Vaccine; 2019 Oct; 37(43):6526-6534. PubMed ID: 31500967
[TBL] [Abstract][Full Text] [Related]
5. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
7. Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Lekcharoensuk P; Wiriyarat W; Petcharat N; Lekcharoensuk C; Auewarakul P; Richt JA
Vaccine; 2012 Feb; 30(8):1453-9. PubMed ID: 22230579
[TBL] [Abstract][Full Text] [Related]
8. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
[TBL] [Abstract][Full Text] [Related]
9. Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor.
Sun B; Yu X; Kong W; Sun S; Yang P; Zhu C; Zhang H; Wu Y; Chen Y; Shi Y; Zhang X; Jiang C
Appl Microbiol Biotechnol; 2013 Feb; 97(3):1063-70. PubMed ID: 22945265
[TBL] [Abstract][Full Text] [Related]
10. Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production.
Abdoli A; Soleimanjahi H; Jamali A; Mehrbod P; Gholami S; Kianmehr Z; Feizi N; Saleh M; Bahrami F; Mokhtari-Azad T; Abdoli M; Kheiri MT
Biotechnol Lett; 2016 Jun; 38(6):941-8. PubMed ID: 26945752
[TBL] [Abstract][Full Text] [Related]
11. Higher titers of some H5N1 and recent human H1N1 and H3N2 influenza viruses in Mv1 Lu vs. MDCK cells.
Hamilton SB; Wyatt DE; Wahlgren BT; O'Dowd MK; Morrissey JM; Daniels DE; Lednicky JA
Virol J; 2011 Feb; 8():66. PubMed ID: 21314955
[TBL] [Abstract][Full Text] [Related]
12. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
Zhang W; Xue T; Wu X; Zhang P; Zhao G; Peng D; Hu S; Wang X; Liu X; Liu W; Liu X
Vaccine; 2011 Oct; 29(45):8032-41. PubMed ID: 21864614
[TBL] [Abstract][Full Text] [Related]
13. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
Hussain AI; Cordeiro M; Sevilla E; Liu J
Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
[TBL] [Abstract][Full Text] [Related]
14. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
[TBL] [Abstract][Full Text] [Related]
15. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
[TBL] [Abstract][Full Text] [Related]
16. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
[TBL] [Abstract][Full Text] [Related]
17. Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells.
Murakami S; Horimoto T; Mai le Q; Nidom CA; Chen H; Muramoto Y; Yamada S; Iwasa A; Iwatsuki-Horimoto K; Shimojima M; Iwata A; Kawaoka Y
J Virol; 2008 Nov; 82(21):10502-9. PubMed ID: 18768983
[TBL] [Abstract][Full Text] [Related]
18. Isolation of the pandemic (H1N1) 2009 virus and its reassortant with an H3N2 swine influenza virus from healthy weaning pigs in Thailand in 2011.
Hiromoto Y; Parchariyanon S; Ketusing N; Netrabukkana P; Hayashi T; Kobayashi T; Takemae N; Saito T
Virus Res; 2012 Oct; 169(1):175-81. PubMed ID: 22906589
[TBL] [Abstract][Full Text] [Related]
19. Development of high-yield influenza A virus vaccine viruses.
Ping J; Lopes TJS; Nidom CA; Ghedin E; Macken CA; Fitch A; Imai M; Maher EA; Neumann G; Kawaoka Y
Nat Commun; 2015 Sep; 6():8148. PubMed ID: 26334134
[TBL] [Abstract][Full Text] [Related]
20. Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
Chu C; Lugovtsev V; Lewis A; Betenbaugh M; Shiloach J
Vaccine; 2010 Oct; 28(44):7193-201. PubMed ID: 20800699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
